Submitting risk management plans draft guidance document: Opioid products

Opioid products need to include specific content within their RMP to address: the risk and uncertainties of opioid-related harms in Canada and other risks and uncertainties posed by the product, where warranted.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2024-04-04

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data